Powder: -20°C for 3 years | In solvent: -80°C for 1 year
UBP714 is a derivative of the NMDA receptor negative allosteric modulator UBP608. It also enhanced NMDAR mediated field EPSPs in the CA1 region of the hippocampus. UBP714 is a novel template for the development of potent and subunit selective NMDAR potentiators that may have therapeutic applicability in the therapy of patients with schizophrenia or cognitive deficits.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | UBP714 is a derivative of the NMDA receptor negative allosteric modulator UBP608. It also enhanced NMDAR mediated field EPSPs in the CA1 region of the hippocampus. UBP714 is a novel template for the development of potent and subunit selective NMDAR potentiators that may have therapeutic applicability in the therapy of patients with schizophrenia or cognitive deficits. |
Synonyms | UBP 714, UBP-714 |
Molecular Weight | 283.07 |
Formula | C11H7BrO4 |
CAS No. | 773109-55-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
UBP714 773109-55-0 UBP 714 UBP-714 inhibitor inhibit